OCUL
Ocular Therapeutix·NASDAQ
--
--(--)
--
--(--)
7.86 / 10
Outperform
Analyst consensus is 100% Strong Buy from three firms, with two analysts showing ~60% win rates. Fund‑flow score is 7.8/10 (good), showing inflows for block, small and extra‑large investors but outflows for medium and large. Sentiment is bullish despite a 12.5% price drop.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-03
InstitutionClear Street
Times predicted1
Historical Win Rate0.0%
Is money flowing into or out of OCUL?
- OCUL holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 7.86/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
